|
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid
|
1R37CA230400-01
|
$374,578
|
$374,578
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-09
|
$1,244,620
|
$1,244,620
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
|
5R01CA204968-03
|
$506,098
|
$506,098
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Highly Accelerated Chemical Exchange Saturation Transfer MRI Using Compressed Sensing
|
1R21CA227783-01A1
|
$178,056
|
$178,056
|
HEO, HYE YOUNG
|
JOHNS HOPKINS UNIVERSITY
|
|
TARGETING ENDOSOMAL PH IN BRAIN TUMOR INITIATING CELLS
|
1F31CA220967-01A1
|
$44,524
|
$44,524
|
KO, MYUNGJUN
|
JOHNS HOPKINS UNIVERSITY
|
|
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging
|
5R01CA200399-03
|
$615,799
|
$615,799
|
LI, XINGDE
|
JOHNS HOPKINS UNIVERSITY
|
|
Optimal DNA Brain-Penetrating Nanoparticle (DNA-BPN) Formulation for Glioblastoma (GBM) Treatment
|
5F31CA210610-03
|
$44,524
|
$44,524
|
NEGRON, KARINA
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S1
|
$59,984
|
$3,599
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S2
|
$199,060
|
$11,944
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$424,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies
|
1U01CA230691-01
|
$768,614
|
$261,329
|
PAPADOPOULOS, NICKOLAS
|
JOHNS HOPKINS UNIVERSITY
|
|
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
|
5R01CA190223-04
|
$370,575
|
$370,575
|
RIGGINS, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
|
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer
|
1K08CA230179-01
|
$270,192
|
$270,192
|
STAEDTKE, VERENA
|
JOHNS HOPKINS UNIVERSITY
|
|
Serum metabolomic profiling of glioma risk in the PLCO study
|
ZIA CP010152 10792
|
$52,848
|
$52,848
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Single-cell DNA methylation analysis of human cancer
|
ZIA BC 011846
|
$218,409
|
$174,727
|
Aldape, Kenneth
|
CCR (NCI)
|
|
Development and validation of a predictor of meningioma recurrence
|
ZIA BC 011847
|
$72,803
|
$72,803
|
Aldape, Kenneth
|
CCR (NCI)
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$16,528
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Natural History and Specimen Banking for Patients with CNS Tumors
|
ZIA BC 011768
|
$416,202
|
$416,202
|
Armstrong, Terri
|
CCR (NCI)
|
|
Outcomes and Risk of Rare Tumors
|
ZIA BC 011837
|
$138,734
|
$138,734
|
Armstrong, Terri
|
CCR (NCI)
|
|
NOB-018 Mouse Model of CNS Radiation-Induced Hypersomnia
|
ZIG BC 011836
|
$138,734
|
$138,734
|
Armstrong, Terri
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$358,849
|
$35,885
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$138,413
|
Barr, Frederic
|
CCR (NCI)
|
|
Cancer in professionals exposed to formaldehyde
|
ZIA CP010120 02094
|
$21,144
|
$5,286
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Serum Markers of Immunity & Risk of Brain tumors
|
ZIA CP010219 10408
|
$25,970
|
$25,970
|
Berrington, Amy
|
DCEG (NCI)
|
|
Pediatric CT Scans
|
ZIA CP010222 04122
|
$37,589
|
$11,277
|
Berrington, Amy
|
DCEG (NCI)
|
|
Radiobiology Outreach
|
ZIA CP010222 10441
|
$66,403
|
$6,640
|
Berrington, Amy
|
DCEG (NCI)
|
|
Pediatric CT Examinations in Israel
|
ZIA CP010222 10543
|
$66,403
|
$26,561
|
Berrington, Amy
|
DCEG (NCI)
|
|
Pooled analysis of radiation related brain tumors
|
ZIA CP010222 10559
|
$110,671
|
$110,671
|
Berrington, Amy
|
DCEG (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
$66,119
|
Beutler, John
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
$39,644
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$387,112
|
$116,134
|
Buck, Christopher
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$6,571
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$354,054
|
$247,838
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$826,126
|
$536,982
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$856,456
|
Camphausen, Kevin
|
CCR (NCI)
|
|
VHL
|
ZIA CP005803 08290
|
$52,954
|
$15,886
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Laboratory of Genetic Susceptibility (LGS)
|
ZIA CP010227 10729
|
$620,014
|
$62,001
|
Chanock, Stephen
|
DCEG (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$474,287
|
$94,857
|
Daar, Ira
|
CCR (NCI)
|
|
Rare Tumor Patient Engagement Network - Cures
|
ZID BC 011856
|
$286,416
|
$143,208
|
Dahut, William
|
CCR (NCI)
|
|
Effects of Cytosine Modifications on Transcription Factor Binding
|
ZIC BC 011724
|
$143,307
|
$143,307
|
Durell, Stewart
|
CCR (NCI)
|
|
Cancer risk in HIV-exposed uninfected children related to early-life exposure to
|
ZIA CP010150 10825
|
$17,044
|
$8,522
|
Engels, Eric
|
DCEG (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$732,342
|
$36,617
|
Figg, William
|
CCR (NCI)
|
|
Cancer Risk in Myotonic Dystrophy
|
ZIA CP010144 10568
|
$153,082
|
$30,616
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 011640
|
$217,982
|
$217,982
|
Gilbert, Mark
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors & Oncogenes
|
ZIA BC 011647
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Immunotherapy
|
ZIA BC 011714
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Bioinformatics: Characterizing Brain Tumor Data
|
ZIA BC 011784
|
$87,193
|
$87,193
|
Gilbert, Mark
|
CCR (NCI)
|
Total relevant funding to Brain for this search: $26,782,038
|